Tunable ciprofloxacin delivery through personalized electrospun patches for tympanic membrane perforations

Shivesh Anand1, Alessandra Fusco2,3, Cemre Günday4

  • 1Department of Complex Tissue Regeneration, MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, 6229 ER, Maastricht, the Netherlands.

PubMed

Insights

This study developed novel biomimetic scaffolds for tympanic membrane (TM) regeneration and localized ciprofloxacin (CIP) release, offering a promising treatment for otitis media and hearing loss.

Area of Science:

  • Biomaterials Science
  • Regenerative Medicine
  • Drug Delivery Systems

Background:

  • Otitis media affects millions annually, often causing tympanic membrane (TM) perforations and hearing impairment.
  • Current antibiotic treatments for otitis media require high dosages due to poor drug concentration at the affected site.
  • There is a need for advanced therapeutic strategies that promote TM healing and effective localized drug delivery.

Purpose of the Study:

  • To engineer biomimetic scaffolds for TM regeneration.
  • To develop localized drug delivery systems for ciprofloxacin (CIP) release.
  • To evaluate the efficacy of these scaffolds in treating otitis media.

Main Methods:

  • Fabrication of electrospun (ES) scaffolds by blending CIP into polymer solutions or using nanoparticle-based co-ES/electrospraying.
  • Investigating different ES modalities and their combinations for controlled CIP release.
  • Assessing scaffold mechanical properties, cell viability, and antibacterial efficacy.

Main Results:

  • Achieved diverse release kinetic profiles from fabricated scaffolds, enabling tailored CIP concentrations.
  • CIP incorporation favorably influenced the mechanical properties of the TM patches.
  • Biological studies confirmed no cytotoxic or anti-proliferative effects of released CIP on human mesenchymal stromal cells.
  • Antibacterial assays validated the efficacy of CIP-loaded scaffolds against bacterial infections.

Conclusions:

  • The developed biomimetic scaffolds effectively promote TM regeneration and localized CIP delivery.
  • These scaffolds offer a promising therapeutic approach for otitis media, addressing challenges of drug delivery and hearing restoration.
  • The study highlights the potential of integrating tissue engineering and drug delivery for otologic applications.